Qualitative Study on Detection & Tx of NSCLC in Pts w/ a History of Alcohol or SUD
- Conditions
- Lung Non-Small Cell Carcinoma
- Registration Number
- NCT07186699
- Lead Sponsor
- University of Southern California
- Brief Summary
This study will attempt to identify social facilitators and barriers to detection and treatment of non-small cell lung cancer in order to learn how a history of substance abuse or alcohol use impacts care for non-small cell lung cancer.
- Detailed Description
PRIMARY OBJECTIVE:
I. To identify social facilitators and barriers to detection and treatment of NSCLC by interviewing a diverse group of patients at Keck, Los Angeles General Medical Center, and Norris Cancer Center with alcohol or substance use disorder history.
OUTLINE: This is an observational study.
Patients participate in a semi-structured interview and may participate in a follow-up focus group interview in which preliminary findings are shared and feedback is elicited on study.
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 45
-
* Adults β₯ 18 years of age
- Histopathologic or cytologic diagnosis of NSCLC
- Received or receiving curative intent treatment (e.g. surgery, radiation therapy, systemic therapy)
- History of alcohol use or substance use disorder (other than tobacco use disorder) within the past 10 years, predating the cancer diagnosis
- Ability to understand and the willingness to sign a written informed consent
- English or Spanish speaking. Due to need to conduct semi-structured interviews which can develop into free-flowing conversations we need both participant and interviewer to be fluent
- Patients with cognitive disability unable to maintain 30-60 minute conversation
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Thematic saturation Up to 3 years Will use a Danaher framework to approach analyze interview data using NVivo software (NVivo version 11.0, QSR International). Each interview will be analyzed to identify broad themes.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (2)
Los Angeles General Medical Center
πΊπΈLos Angeles, California, United States
USC / Norris Comprehensive Cancer Center
πΊπΈLos Angeles, California, United States
Los Angeles General Medical CenterπΊπΈLos Angeles, California, United StatesSandy TranContact323-865-3935sandy.tran@med.usc.eduBrooks V. UdelsmanPrincipal Investigator